These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
314 related articles for article (PubMed ID: 36168628)
1. The N Li B; Zhao R; Qiu W; Pan Z; Zhao S; Qi Y; Qiu J; Zhang S; Guo Q; Fan Y; Xu H; Li M; Li G; Xue H Theranostics; 2022; 12(14):6363-6379. PubMed ID: 36168628 [No Abstract] [Full Text] [Related]
2. Long Noncoding RNA WEE2-AS1 Plays an Oncogenic Role in Glioblastoma by Functioning as a Molecular Sponge for MicroRNA-520f-3p. Lin H; Zuo D; He J; Ji T; Wang J; Jiang T Oncol Res; 2021 Mar; 28(6):591-603. PubMed ID: 32838835 [TBL] [Abstract][Full Text] [Related]
3. [Study on the Role and Mechanism of METTL3 Mediating the Up-regulation of m6A Modified Long Non-coding RNA THAP7-AS1 in Promoting the Occurrence of Lung Cancer]. Zhang Y; Wang Y; Liu M Zhongguo Fei Ai Za Zhi; 2024 Jan; 26(12):919-933. PubMed ID: 38163978 [TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus X protein related lncRNA WEE2-AS1 promotes hepatocellular carcinoma proliferation and invasion. Hu Z; Huang P; Yan Y; Zhou Z; Wang J; Wu G Biochem Biophys Res Commun; 2019 Jan; 508(1):79-86. PubMed ID: 30471857 [TBL] [Abstract][Full Text] [Related]
5. METTL3-mediated m6A modification of lnc RNA RHPN1-AS1 enhances cisplatin resistance in ovarian cancer by activating PI3K/AKT pathway. Cui S J Clin Lab Anal; 2022 Dec; 36(12):e24761. PubMed ID: 36336887 [TBL] [Abstract][Full Text] [Related]
6. m6A- and m5C- modified lncRNAs orchestrate the prognosis in cutaneous melanoma and m6A- modified LINC00893 regulates cutaneous melanoma cell metastasis. Shi HZ; Tian CC; Wu MY; Ma L; Sun JF; Chen H Skin Res Technol; 2024 Jul; 30(7):e13842. PubMed ID: 38965799 [TBL] [Abstract][Full Text] [Related]
7. LncRNA PITPNA-AS1 stimulates cell proliferation and suppresses cell apoptosis in glioblastoma via targeting miR-223-3p/EGFR axis and activating PI3K/AKT signaling pathway. Geng S; Tu S; Fu W; Wang J; Bai Z Cell Cycle; 2021 Oct; 20(19):1988-1998. PubMed ID: 34470587 [TBL] [Abstract][Full Text] [Related]
8. LncRNA WEE2-AS1 promotes proliferation and inhibits apoptosis in triple negative breast cancer cells via regulating miR-32-5p/TOB1 axis. Wang R; Huang Z; Qian C; Wang M; Zheng Y; Jiang R; Yu C Biochem Biophys Res Commun; 2020 Jun; 526(4):1005-1012. PubMed ID: 32307083 [TBL] [Abstract][Full Text] [Related]
9. M Chen JQ; Tao YP; Hong YG; Li HF; Huang ZP; Xu XF; Zheng H; Hu LK Cell Cycle; 2021 Dec; 20(23):2507-2518. PubMed ID: 34658294 [TBL] [Abstract][Full Text] [Related]
10. AGAP2-AS1 promotes the assembly of m6A methyltransferases and activation of the IL6/STAT3 pathway by binding with WTAP in the carcinogenesis of gastric cancer. Nie K; Zheng Z; Li J; Chang Y; Deng Z; Huang W; Li X FASEB J; 2023 Dec; 37(12):e23302. PubMed ID: 37983949 [TBL] [Abstract][Full Text] [Related]
11. A reciprocal feedback between N6-methyladenosine reader YTHDF3 and lncRNA DICER1-AS1 promotes glycolysis of pancreatic cancer through inhibiting maturation of miR-5586-5p. Hu Y; Tang J; Xu F; Chen J; Zeng Z; Han S; Wang F; Wang D; Huang M; Zhao Y; Huang Y; Zhuo W; Zhao G J Exp Clin Cancer Res; 2022 Feb; 41(1):69. PubMed ID: 35183226 [TBL] [Abstract][Full Text] [Related]
12. N6-methyladenosine modification of OIP5-AS1 promotes glycolysis, tumorigenesis, and metastasis of gastric cancer by inhibiting Trim21-mediated hnRNPA1 ubiquitination and degradation. Xie R; Liu L; Lu X; He C; Yao H; Li G Gastric Cancer; 2024 Jan; 27(1):49-71. PubMed ID: 37897508 [TBL] [Abstract][Full Text] [Related]
13. lncRNA THAP7-AS1, transcriptionally activated by SP1 and post-transcriptionally stabilized by METTL3-mediated m6A modification, exerts oncogenic properties by improving CUL4B entry into the nucleus. Liu HT; Zou YX; Zhu WJ; Sen-Liu ; Zhang GH; Ma RR; Guo XY; Gao P Cell Death Differ; 2022 Mar; 29(3):627-641. PubMed ID: 34608273 [TBL] [Abstract][Full Text] [Related]
14. Hypoxia-induced lncRNA STEAP3-AS1 activates Wnt/β-catenin signaling to promote colorectal cancer progression by preventing m Zhou L; Jiang J; Huang Z; Jin P; Peng L; Luo M; Zhang Z; Chen Y; Xie N; Gao W; Nice EC; Li JQ; Chen HN; Huang C Mol Cancer; 2022 Aug; 21(1):168. PubMed ID: 35986274 [TBL] [Abstract][Full Text] [Related]
15. Identification and comparison of m6A modifications in glioblastoma non-coding RNAs with MeRIP-seq and Nanopore dRNA-seq. Krusnauskas R; Stakaitis R; Steponaitis G; Almstrup K; Vaitkiene P Epigenetics; 2023 Dec; 18(1):2163365. PubMed ID: 36597408 [TBL] [Abstract][Full Text] [Related]
16. M6A RNA Methylation-Mediated Dysregulation of AGAP2-AS1 Promotes Trastuzumab Resistance of Breast Cancer. Cai Y; Zheng H; Xu D; Xie J; Wang W; Liu Z; Zheng Z Pharmacology; 2024; 109(5):282-292. PubMed ID: 38744264 [TBL] [Abstract][Full Text] [Related]
17. CAF-derived exosomal WEE2-AS1 facilitates colorectal cancer progression via promoting degradation of MOB1A to inhibit the Hippo pathway. Yang P; Zhang D; Wang T; Ji J; Jin C; Peng C; Tan Y; Zhou J; Wang L; Feng Y; Sun Y Cell Death Dis; 2022 Sep; 13(9):796. PubMed ID: 36123327 [TBL] [Abstract][Full Text] [Related]
18. FOXD1-AS1 regulates FOXD1 translation and promotes gastric cancer progression and chemoresistance by activating the PI3K/AKT/mTOR pathway. Wu Q; Ma J; Wei J; Meng W; Wang Y; Shi M Mol Oncol; 2021 Jan; 15(1):299-316. PubMed ID: 32460412 [TBL] [Abstract][Full Text] [Related]
19. YTHDF1 Promotes Bladder Cancer Cell Proliferation via the METTL3/YTHDF1-RPN2-PI3K/AKT/mTOR Axis. Zhu J; Tong H; Sun Y; Li T; Yang G; He W Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108067 [TBL] [Abstract][Full Text] [Related]
20. LncRNA SLC7A11-AS1 promotes the progression of hepatocellular carcinoma by mediating KLF9 ubiquitination. Zeng FL; Lin J; Xie X; Xie YK; Zhang JH; Xu D; He X; Liu FE; Xie BH Neoplasma; 2023 Jun; 70(3):361-374. PubMed ID: 37498069 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]